Mastrototaro Lucia, Tietjen Uwe, Sponder Gerhard, Vormann Jürgen, Aschenbach Jörg R, Kolisek Martin
Institute of Veterinary Physiology, Freie Universität, Berlin, Germany; and.
Institute for Prevention and Nutrition, Ismaning/Munich, Germany.
J Nutr. 2015 Nov;145(11):2440-7. doi: 10.3945/jn.115.213918. Epub 2015 Sep 9.
Magnesium deficiency is a common complication of diabetes with an unclear molecular background.
We investigated the effect of the insulin (INS)-signaling pathway (ISP) on the regulation of Mg(2+) efflux (Mg(2+)E) conducted by solute carrier family 41, member A1 (SLC41A1; activated by protein kinase A) in transgenic human embryonic kidney (HEK) 293 cells.
HEK293 cells overexpressing SLC41A1 were loaded with the Mg(2+) fluorescent indicator mag-fura-2 and Mg(2+). Measurements of Mg(2+)E were conducted in Mg(2+)-free buffer by using fast-filter fluorescence spectrometry. We examined the effects of INS, inhibitors of ISP or p38 mitogen-activated protein kinase (p38 MAPK), an activator of adenylate cyclase (ADC), and their combinations on SLC41A1-attributed Mg(2+)E.
The application of 400 μU/mL INS inhibited SLC41A1-mediated Mg(2+)E by up to 50.6% compared with INS-untreated cells (P < 0.001). Moreover, INS evoked the early onset of Mg(2+) release from intracellular stores. The application of 0.1 μM wortmannin or 10 μM zardaverine (both ISP inhibitors) restored SLC41A1 Mg(2+)E capacity in the presence of INS to the same levels in INS-untreated cells. The simultaneous application of 10 μM forskolin, an ADC activator, and INS resulted in a reduction of Mg(2+)E of up to 59% compared with untreated cells (P < 0.001), which was comparable to that in cells treated with INS alone. Inhibition of p38 MAPK with 10 μM SB 202190 (SB) in the absence of INS resulted in a decrease (P < 0.001) of SLC41A1-dependent Mg(2+)E (by up to 49%) compared with Mg(2+)E measured in untreated cells. Simultaneous exposure of cells to SB and INS had a stronger inhibitory effect on SLC41A1 activity than INS alone (P < 0.05).
INS affects intracellular Mg(2+) concentration in transgenic HEK293 cells by regulating SLC41A1 activity (via ISP) and by influencing the compartmentalization and cellular distribution of Mg(2+). In addition, p38 MAPK activates SLC41A1 independently of INS action.
镁缺乏是糖尿病常见的并发症,其分子机制尚不清楚。
我们研究了胰岛素(INS)信号通路(ISP)对溶质载体家族41成员A1(SLC41A1;由蛋白激酶A激活)在转基因人胚肾(HEK)293细胞中介导的镁离子外流(Mg(2+)E)的调节作用。
将过表达SLC41A1的HEK293细胞用镁离子荧光指示剂mag-fura-2和镁离子进行负载。在无镁离子缓冲液中使用快速过滤荧光光谱法测量Mg(2+)E。我们研究了INS、ISP抑制剂或p38丝裂原活化蛋白激酶(p38 MAPK)、腺苷酸环化酶(ADC)激活剂及其组合对SLC41A1介导的Mg(2+)E的影响。
与未处理INS的细胞相比,施加400 μU/mL INS可使SLC41A1介导的Mg(2+)E抑制高达50.6%(P < 0.001)。此外,INS引起细胞内储存镁离子的早期释放。施加0.1 μM渥曼青霉素或10 μM扎达维林(均为ISP抑制剂)可使存在INS时SLC41A1的Mg(2+)E能力恢复到未处理INS细胞的相同水平。同时施加10 μM福斯可林(一种ADC激活剂)和INS,与未处理细胞相比,可使Mg(2+)E降低高达59%(P < 0.001),这与单独用INS处理的细胞相当。在不存在INS的情况下,用10 μM SB 202190(SB)抑制p38 MAPK导致与未处理细胞中测量的Mg(2+)E相比,SLC41A1依赖性Mg(2+)E降低(P < 0.001)(高达49%)。细胞同时暴露于SB和INS对SLC41A1活性的抑制作用比单独使用INS更强(P < 0.05)。
INS通过调节SLC41A1活性(通过ISP)以及影响镁离子的区室化和细胞分布来影响转基因HEK293细胞内的镁离子浓度。此外,p38 MAPK独立于INS作用激活SLC41A1。